The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Taxol stabilizes microtubules in mouse fibroblast cells.
Open accessAbstract
Taxol, a potent inhibitor of human HeLa and mouse fibroblast cell replication, blocked cells in the G2 and M phase of the cell cycle and stabilized cytoplasmic microtubules. The cytoplasmic microtubules of taxol-treated cells were visualized by transmission electron microscopy and indirect immunofluorescence microscopy. More than 90% of the cells treated with 10 micro M taxol for 22 hr at 37 degrees C displayed bundles of microtubules that appeared to radiate from a common site (or sites), in addition to their cytoplasmic microtubules. Untreated cells that were kept in the cold (4 degrees C) for 16 hr lost their microtubules, whereas cells that were pretreated with taxol for 22 hr at 37 degrees C continued to display their microtubules and bundles of microtubules in the cold. Taxol inhibited the migration behavior of fibroblast cells, but these cells did not lose their ability to produce mobile surface projections such as lamellipodia and filopodia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wani, M. C., Taylor, H. L., Wall, M. E., Coggon, P., & McPhail, A. T. (1971) · Journal of the American Chemical Society · doi:10.1021/ja00738a045 · Cited by 4,073
Promotion of microtubule assembly in vitro by taxol
SCHIFF, P. B., FANT, J., & HORWITZ, S. B. (1979) · Nature · doi:10.1038/277665a0 · Cited by 3,600
Self-citationThe locomotion of fibroblasts in culture
Abercrombie, M., Heaysman, J. E. M., & Pegrum, S. M. (1971) · Experimental Cell Research · doi:10.1016/0014-4827(71)90420-4 · Cited by 965
Cell Motility by Labile Association of Molecules
Inoué, S., & Sato, H. (1967) · The Journal of General Physiology · doi:10.1085/jgp.50.6.259 · Cited by 757
Crissman, H. A., & Steinkamp, J. A. (1973) · The Journal of Cell Biology · doi:10.1083/jcb.59.3.766 · Cited by 544
The phagokinetic tracks of 3T3 cells
Albrecht-Buehler, G. (1977) · Cell · doi:10.1016/0092-8674(77)90057-5 · Cited by 423
The locomotion of fibroblasts in culture I. Movements of the leading edge
Abercrombie, M., Heaysman, J. E. M., & Pegrum, S. M. (1970) · Experimental Cell Research · doi:10.1016/0014-4827(70)90646-4 · Cited by 402
Effect of colcemid on the locomotory behaviour of fibroblasts
Vasiliev, J. M., Gelfand, I. M., Domnina, L. V., Ivanova, O. Y., Komm, S. G., & Olshevskaja, L. V. (1970) · Development · doi:10.1242/dev.24.3.625 · Cited by 340
The locomotion of fibroblasts in culture
Abercrombie, M., Joan, E., Heaysman, M., & Pegrum, S. M. (1970) · Experimental Cell Research · doi:10.1016/0014-4827(70)90537-9 · Cited by 310
Osborn, M., & Weber, K. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.3.867 · Cited by 265
Cited by
Natural products: A continuing source of novel drug leads
Cragg, G. M., & Newman, D. J. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.02.008 · Cited by 2,906
Discovery and resupply of pharmacologically active plant-derived natural products: A review
Atanasov, A. G., Waltenberger, B., Pferschy-Wenzig, E.-M., Linder, T., Wawrosch, C., Uhrin, P., Temml, V., Wang, L., Schwaiger, S., Heiss, E. H., et al. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.08.001 · Cited by 2,904
Bioprospecting for Microbial Endophytes and Their Natural Products
Strobel, G., & Daisy, B. (2003) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.67.4.491-502.2003 · Cited by 2,359
Rowinsky, E. K., & Donehower, R. C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504133321507 · Cited by 1,924
Taxol and Taxane Production by Taxomyces andreanae , an Endophytic Fungus of Pacific Yew
Stierle, A., Strobel, G., & Stierle, D. (1993) · Science · doi:10.1126/science.8097061 · Cited by 1,701
How Taxol/paclitaxel kills cancer cells
Weaver, B. A. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-04-0916 · Cited by 1,547
Natural Products from Endophytic Microorganisms
Strobel, G., Daisy, B., Castillo, U., & Harper, J. (2004) · Journal of Natural Products · doi:10.1021/np030397v · Cited by 1,465
Structural and Chemical Biology of Terpenoid Cyclases
Christianson, D. W. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00287 · Cited by 1,223
Microtubules and resistance to tubulin-binding agents
Kavallaris, M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2803 · Cited by 1,120
Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations.
Jordan, M. A., Toso, R. J., Thrower, D., & Wilson, L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9552 · Cited by 1,095
Cyclin D–CDK4 kinase destabilizes PD-L1 via cullin 3–SPOP to control cancer immune surveillance
Zhang, J., Bu, X., Wang, H., Zhu, Y., Geng, Y., Nihira, N. T., Tan, Y., Ci, Y., Wu, F., Dai, X., et al. (2018) · Nature · doi:10.1038/nature25015 · Cited by 1,013
Endophytes as sources of bioactive products
Strobel, G. A. (2003) · Microbes and Infection · doi:10.1016/s1286-4579(03)00073-x · Cited by 991
Microtubules containing acetylated alpha-tubulin in mammalian cells in culture.
Piperno, G., LeDizet, M., & Chang, X. J. (1987) · The Journal of cell biology · doi:10.1083/jcb.104.2.289 · Cited by 873
“Cytoplasmic microtubules, which normally disassemble and assemble at high rates, in the presence of taxol bind the drug and are stabilized (13).”
BackgroundHelper T Cell Differentiation Is Controlled by the Cell Cycle
Bird, J. J., Brown, D. R., Mullen, A. C., Moskowitz, N. H., Mahowald, M. A., Sider, J. R., Gajewski, T. F., Wang, C.-R., & Reiner, S. L. (1998) · Immunity · doi:10.1016/s1074-7613(00)80605-6 · Cited by 832
Axel, D. I., Kunert, W., Göggelmann, C., Oberhoff, M., Herdeg, C., Küttner, A., Wild, D. H., Brehm, B. R., Riessen, R., Köveker, G., et al. (1997) · Circulation · doi:10.1161/01.cir.96.2.636 · Cited by 784
Protein nanoparticles as drug carriers in clinical medicine
Hawkins, M. J., Soon-Shiong, P., & Desai, N. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.044 · Cited by 779
Mechanisms of Taxol resistance related to microtubules
Orr, G. A., Verdier-Pinard, P., McDaid, H., & Horwitz, S. B. (2003) · Oncogene · doi:10.1038/sj.onc.1206934 · Cited by 727
Self-citationCYCLINS AND CELL CYCLE CHECKPOINTS
Johnson, D. G., & Walker, C. L. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.295 · Cited by 719
Albumin-bound paclitaxel: a next-generation taxane
Gradishar, W. J. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.8.1041 · Cited by 712
Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer
Tomao, S. (2009) · International Journal of Nanomedicine · doi:10.2147/ijn.s3061 · Cited by 695
Giannakakou, P., Sackett, D. L., Kang, Y.-K., Zhan, Z., Buters, J. T. M., Fojo, T., & Poruchynsky, M. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.27.17118 · Cited by 681
Paclitaxel-induced cell death: Where the cell cycle and apoptosis come together
Wang, T.-H., Wang, H.-S., & Soong, Y.-K. (2000) · Cancer · doi:10.1002/1097-0142(20000601)88:11<2619::aid-cncr26>3.0.co;2-j · Cited by 647
Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis
Wahl, A. F., Donaldson, K. L., Faircnild, C., Lee, F. Y. F., Foster, S. A., Demers, G. W., & Galloway, D. A. (1996) · Nature Medicine · doi:10.1038/nm0196-72 · Cited by 646
Chemistry and Biology of Taxol
Nicolaou, K. C., Dai, W., & Guy, R. K. (1994) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199400151 · Cited by 623
Taxol binds to polymerized tubulin in vitro
Parness, J., & Horwitz, S. (1981) · The Journal of Cell Biology · doi:10.1083/jcb.91.2.479 · Cited by 620
Self-citationMicrotubules and actin filaments: dynamic targets for cancer chemotherapy
Jordan, M. A., & Wilson, L. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80095-1 · Cited by 614
Kavallaris, M., Kuo, D. Y., Burkhart, C. A., Regl, D. L., Norris, M. D., Haber, M., & Horwitz, S. B. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119642 · Cited by 601
Self-citationTaxol from Pestalotiopsis microspora, an endophytic fungus of Taxus wallachiana
Strobel, G., Yang, X., Sears, J., Kramer, R., Sidhu, R. S., & Hess, W. M. (1996) · Microbiology · doi:10.1099/13500872-142-2-435 · Cited by 593
MacKeigan, J. P., Murphy, L. O., & Blenis, J. (2005) · Nature Cell Biology · doi:10.1038/ncb1258 · Cited by 561
Taxol Suppresses Dynamics of Individual Microtubules in Living Human Tumor Cells
Yvon, A.-M. C., Wadsworth, P., & Jordan, M. A. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.4.947 · Cited by 553
Vallee, R. B. (1982) · The Journal of cell biology · doi:10.1083/jcb.92.2.435 · Cited by 551
Tau protein binds to microtubules through a flexible array of distributed weak sites.
Butner, K. A., & Kirschner, M. W. (1991) · The Journal of cell biology · doi:10.1083/jcb.115.3.717 · Cited by 550
Ann Jordan, M., Thrower, D., & Wilson, L. (1992) · Journal of Cell Science · doi:10.1242/jcs.102.3.401 · Cited by 531
Paclitaxel: a review of adverse toxicities and novel delivery strategies
Marupudi, N. I., Han, J. E., Li, K. W., Renard, V. M., Tyler, B. M., & Brem, H. (2007) · Expert Opinion on Drug Safety · doi:10.1517/14740338.6.5.609 · Cited by 510
nab-Paclitaxel mechanisms of action and delivery
Yardley, D. A. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.05.041 · Cited by 508
Kodumudi, K. N., Woan, K., Gilvary, D. L., Sahakian, E., Wei, S., & Djeu, J. Y. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0733 · Cited by 500
Microtubule growth activates Rac1 to promote lamellipodial protrusion in fibroblasts
Waterman-Storer, C. M., Worthylake, R. A., Liu, B. P., Burridge, K., & Salmon, E. D. (1999) · Nature Cell Biology · doi:10.1038/9018 · Cited by 491
Taxol: an antimitotic agent with a new mechanism of action
Manfredi, J. J., & Horwitz, S. B. (1984) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(84)90025-1 · Cited by 483
Self-citationMicrotubules, microtubule-interfering agents and apoptosis
Mollinedo, F., & Gajate, C. (2003) · Apoptosis · doi:10.1023/a:1025513106330 · Cited by 477
A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel
Polomano, R. C., Mannes, A. J., Clark, U. S., & Bennett, G. J. (2001) · Pain · doi:10.1016/s0304-3959(01)00363-3 · Cited by 476
The concurrent chemoradiation paradigm—general principles
Seiwert, T. Y., Salama, J. K., & Vokes, E. E. (2007) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0714 · Cited by 443
Heldman, A. W., Cheng, L., Jenkins, G. M., Heller, P. F., Kim, D.-W., Ware, M., Nater, C., Hruban, R. H., Rezai, B., Abella, B. S., et al. (2001) · Circulation · doi:10.1161/01.cir.103.18.2289 · Cited by 435
Cytotoxic studies of paclitaxel (Taxol®) in human tumour cell lines
Liebmann, J., Cook, J., Lipschultz, C., Teague, D., Fisher, J., & Mitchell, J. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.488 · Cited by 428
Pathological Analysis of Local Delivery of Paclitaxel Via a Polymer-Coated Stent
Farb, A., Heller, P. F., Shroff, S., Cheng, L., Kolodgie, F. D., Carter, A. J., Scott, D. S., Froehlich, J., & Virmani, R. (2001) · Circulation · doi:10.1161/hc3001.092037 · Cited by 423
Taxol: Mechanisms of Action and Resistancea
HORWITZ, S. B., LOTHSTEIN, L., MANFREDI, J. J., MELLADO, W., PARNESS, J., ROY, S. N., SCHIFF, P. B., SORBARA, L., & ZEHEB, R. (1986) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1986.tb38455.x · Cited by 416
Self-citationEmerging Strategies of Nanomaterial‐Mediated Tumor Radiosensitization
Xie, J., Gong, L., Zhu, S., Yong, Y., Gu, Z., & Zhao, Y. (2019) · Advanced Materials · doi:10.1002/adma.201802244 · Cited by 415
Diaz, J. F., & Andreu, J. M. (1993) · Biochemistry · doi:10.1021/bi00062a003 · Cited by 411
Taxol binds to cellular microtubules.
Manfredi, J. J., Parness, J., & Horwitz, S. B. (1982) · The Journal of cell biology · doi:10.1083/jcb.94.3.688 · Cited by 409
Self-citationMicrotubules and signal transduction
Gundersen, G. G., & Cook, T. A. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80010-6 · Cited by 407
Zasadil, L. M., Andersen, K. A., Yeum, D., Rocque, G. B., Wilke, L. G., Tevaarwerk, A. J., Raines, R. T., Burkard, M. E., & Weaver, B. A. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007965 · Cited by 402
Taxol-induced polymerization of purified tubulin. Mechanism of action.
Kumar, N. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)68639-4 · Cited by 401
Spencer, C. M., & Faulds, D. (1994) · Drugs · doi:10.2165/00003495-199448050-00009 · Cited by 396
Unpolymerized tubulin modulates the level of tubulin mRNAs
Cleveland, D. W., Lopata, M. A., Sherline, P., & Kirschner, M. W. (1981) · Cell · doi:10.1016/0092-8674(81)90072-6 · Cited by 393
Structure of tubulin at 6.5 Å and location of the taxol-binding site
Nogales, E., Grayer Wolf, S., Khan, I. A., Ludueña, R. F., & Downing, K. H. (1995) · Nature · doi:10.1038/375424a0 · Cited by 389
De Brabander, M., Geuens, G., Nuydens, R., Willebrords, R., & De Mey, J. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.9.5608 · Cited by 387
Taxanes in cancer treatment: Activity, chemoresistance and its overcoming
Mosca, L., Ilari, A., Fazi, F., Assaraf, Y. G., & Colotti, G. (2021) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100742 · Cited by 385
Benzimidazole Fungicides: Mechanism of Action and Biological Impact
Davidse, L. C. (1986) · Annual Review of Phytopathology · doi:10.1146/annurev.py.24.090186.000355 · Cited by 378
Markman, M., & Mekhail, T. M. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.6.755 · Cited by 375
Dougherty, P. M., Cata, J. P., Cordella, J. V., Burton, A., & Weng, H.-R. (2004) · Pain · doi:10.1016/j.pain.2004.01.021 · Cited by 369
Schiff, P. B., & Horwitz, S. B. (1981) · Biochemistry · doi:10.1021/bi00514a041 · Cited by 368
Self-citationTumor acidity, ion trapping and chemotherapeutics
Mahoney, B. P., Raghunand, N., Baggett, B., & Gillies, R. J. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00467-2 · Cited by 364
Molecular effects of paclitaxel: Myths and reality (a critical review)
Blagosklonny, M. V., & Fojo, T. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991008)83:2<151::aid-ijc1>3.0.co;2-5 · Cited by 363
Paclitaxel and Its Evolving Role in the Management of Ovarian Cancer
Kampan, N. C., Madondo, M. T., McNally, O. M., Quinn, M., & Plebanski, M. (2015) · BioMed Research International · doi:10.1155/2015/413076 · Cited by 362
Paclitaxel (TaxolTM) and docetaxel (TaxotereTM): Not simply two of a kind
Verweij, J., Clavel, M., & Chevalier, B. (1994) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a058903 · Cited by 361
Kawasaki, K., Akashi, S., Shimazu, R., Yoshida, T., Miyake, K., & Nishijima, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2251 · Cited by 355
Camptothecin and Taxol: Historic Achievements in Natural Products Research
Oberlies, N. H., & Kroll, D. J. (2004) · Journal of Natural Products · doi:10.1021/np030498t · Cited by 353
Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes
Tsavaris, N., Kosmas, C., Vadiaka, M., Kanelopoulos, P., & Boulamatsis, D. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600347 · Cited by 343
“Increased microtubule stability leads to abnormalities in the cytoskeleton and the mitotic spindle (Schiff and Horwitz, 1980).”
BackgroundRole of Microtubules in the Organization of the Golgi Complex
Thyberg, J., & Moskalewski, S. (1999) · Experimental Cell Research · doi:10.1006/excr.1998.4326 · Cited by 343
Ye, K., Ke, Y., Keshava, N., Shanks, J., Kapp, J. A., Tekmal, R. R., Petros, J., & Joshi, H. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1601 · Cited by 341
Sex Differences in Cancer: Epidemiology, Genetics and Therapy
Kim, H.-I., Lim, H., & Moon, A. (2018) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2018.103 · Cited by 315
The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics
Rowinsky, E. K., & Donehower, R. C. (1991) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(91)90086-2 · Cited by 321
Taxol: A novel radiation sensitizer
Tishler, R. B., Schiff, P. B., Geard, C. R., & Hall, E. J. (1992) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(92)90888-o · Cited by 319
Self-citationRainforest Endophytes and Bioactive Products
Strobel, G. A. (2002) · Critical Reviews in Biotechnology · doi:10.1080/07388550290789531 · Cited by 317
Phase I trial of intraperitoneal taxol: a Gynecoloic Oncology Group study.
Markman, M., Rowinsky, E., Hakes, T., Reichman, B., Jones, W., Lewis, J. L., Rubin, S., Curtin, J., Barakat, R., & Phillips, M. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.9.1485 · Cited by 313
Alexandre, J., Batteux, F., Nicco, C., Chéreau, C., Laurent, A., Guillevin, L., Weill, B., & Goldwasser, F. (2006) · International Journal of Cancer · doi:10.1002/ijc.21685 · Cited by 310
Inhibitors of the HSP90 Molecular Chaperone: Current Status
(2006) · Advances in Cancer Research · doi:10.1016/s0065-230x(06)95009-x · Cited by 310
Prediction of Docetaxel Response in Human Breast Cancer by Gene Expression Profiling
Iwao-Koizumi, K., Matoba, R., Ueno, N., Kim, S. J., Ando, A., Miyoshi, Y., Maeda, E., Noguchi, S., & Kato, K. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.078 · Cited by 309
Fibroblast contractility and actin organization are stimulated by microtubule inhibitors
Danowski, B. A. (1989) · Journal of Cell Science · doi:10.1242/jcs.93.2.255 · Cited by 307
Peterson, J. R., & Mitchison, T. J. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00284-3 · Cited by 307
Paclitaxel Resistance in Non–Small-Cell Lung Cancer Associated With Beta-Tubulin Gene Mutations
Monzó, M., Rosell, R., Sánchez, J. J., Lee, J. S., O'Brate, A., González-Larriba, J. L., Alberola, V., Lorenzo, J. C., Núñez, L., Ro, J. Y., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.6.1786 · Cited by 306
Gundersen, G. G., Khawaja, S., & Bulinski, J. C. (1987) · The Journal of cell biology · doi:10.1083/jcb.105.1.251 · Cited by 304
Chen, Y., Yang, C., & Wang, Z. J. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.06.085 · Cited by 302
Paclitaxel: Application in Modern Oncology and Nanomedicine‐Based Cancer Therapy
Sharifi-Rad, J., Quispe, C., Patra, J. K., Singh, Y. D., Panda, M. K., Das, G., Adetunji, C. O., Michael, O. S., Sytar, O., Polito, L., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/3687700 · Cited by 298
Schliwa, M., Nakamura, T., Porter, K. R., & Euteneuer, U. (1984) · The Journal of cell biology · doi:10.1083/jcb.99.3.1045 · Cited by 297
3-D Tumor Model for In Vitro Evaluation of Anticancer Drugs
Horning, J. L., Sahoo, S. K., Vijayaraghavalu, S., Dimitrijevic, S., Vasir, J. K., Jain, T. K., Panda, A. K., & Labhasetwar, V. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800047v · Cited by 292
Verde, F., Berrez, J. M., Antony, C., & Karsenti, E. (1991) · The Journal of cell biology · doi:10.1083/jcb.112.6.1177 · Cited by 289
Resistance to Paclitaxel Is Proportional to Cellular Total Antioxidant Capacity
Ramanathan, B., Jan, K.-Y., Chen, C.-H., Hour, T.-C., Yu, H.-J., & Pu, Y.-S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1162 · Cited by 287
Relationship of Mitotic Arrest and Apoptosis to Antitumor Effect of Paclitaxel
Milross, C. G., Mason, K. A., Hunter, N. R., Chung, W.-K., Peters, L. J., & Milas, L. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.18.1308 · Cited by 286
Cella, D., Peterman, A., Hudgens, S., Webster, K., & Socinski, M. A. (2003) · Cancer · doi:10.1002/cncr.11578 · Cited by 286
Taxol®: The First Microtubule Stabilizing Agent
Yang, C.-P., & Horwitz, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081733 · Cited by 284
Self-citationTaxol-Induced Mitotic Block Triggers Rapid Onset of a p53-Independent Apoptotic Pathway
Woods, C. M., Zhu, J., McQueney, P. A., Bollag, D., & Lazarides, E. (1995) · Molecular Medicine · doi:10.1007/bf03401588 · Cited by 282
Pinhal-Enfield, G., Ramanathan, M., Hasko, G., Vogel, S. N., Salzman, A. L., Boons, G.-J., & Leibovich, S. J. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63698-x · Cited by 278
“55,56 In addition, in murine, but not human macrophages, taxol acts as an LPS-mi-metic, inducing secretion of TNF (cid:2) , down-regulation of TNF (cid:2) receptors, induction of LPS-inducible gene expression, and activation of NF-(cid”
BackgroundWiernik, P. H., Schwartz, E. L., Einzig, A., Strauman, J. J., Lipton, R. B., & Dutcher, J. P. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.8.1232 · Cited by 275
Cell kill kinetics and cell cycle effects of taxol on human and hamster ovarian cell lines
Lopes, N. M., Adams, E. G., Pitts, T. W., & Bhuyan, B. K. (1993) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00685842 · Cited by 271
Postma, T. J., Vermorken, J. B., Liefting, A. J. M., Pinedo, H. M., & Heimans, J. J. (1995) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a059220 · Cited by 271
Activation of NF-κB by Antineoplastic Agents
Das, K. C., & White, C. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.23.14914 · Cited by 269
Nikitas, G., Deschamps, C., Disson, O., Niault, T., Cossart, P., & Lecuit, M. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110560 · Cited by 268
Einzig, A. I., Wiernik, P. H., Sasloff, J., Runowicz, C. D., & Goldberg, G. L. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.11.1748 · Cited by 263
Ran, X., & Gestwicki, J. E. (2018) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2018.06.004 · Cited by 263
Resistance to Taxol in lung cancer cells associated with increased microtubule dynamics
Gonçalves, A., Braguer, D., Kamath, K., Martello, L., Briand, C., Horwitz, S., Wilson, L., & Jordan, M. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191388598 · Cited by 260
Self-citation
Metadata
- Authors
- Schiff, P. B., & Horwitz, S. B.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1980-03
- Volume
- 77
- Issue
- 3
- Pages
- 1561-1565
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2081406767
- Cited by
- 1,970
- References
- 18
- FWCI
- 13.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.